A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity.

Griffith, Darren; Morgan, Maria P.; Marmion, Celine J.

A novel anti-cancer bifunctional platinum drug candidate with dua.pdf (535.98 kB)

A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity.

Version 2 2021-10-13, 09:33

Version 1 2019-11-23, 11:50

journal contribution

posted on 2019-11-23, 11:50 authored by Darren Griffith, Maria P. Morgan, Celine J. Marmion

The successful design and synthesis of a novel multifunctional platinum drug candidate with DNA binding, histone deacetylase inhibitory activity and enhanced selectivity for cancer cells are described.

History

Comments

This article is also available from http://pubs.rsc.org

Published Citation

Griffith D, Morgan MP, Marmion CJ. A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. Chem Commun (Camb). 2009;44:6735-6737